EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
62.00
+1.00 (1.64%)
At close: Oct 27, 2025
1.64% (1Y)
| Market Cap | 112.51M |
| Revenue (ttm) | 9.71M |
| Net Income (ttm) | 1.30M |
| Shares Out | 1.79M |
| EPS (ttm) | 0.73 |
| PE Ratio | 86.67 |
| Forward PE | n/a |
| Dividend | 1.83 (2.90%) |
| Ex-Dividend Date | Jun 16, 2025 |
| Volume | 30 |
| Average Volume | 71 |
| Open | 62.00 |
| Previous Close | 61.00 |
| Day's Range | 62.00 - 62.00 |
| 52-Week Range | 55.00 - 65.50 |
| Beta | -0.07 |
| RSI | 44.98 |
| Earnings Date | Oct 27, 2025 |